This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Joseph Vogel: Innovator in Bacterial Resistance Treatment
Introduction
Joseph Vogel is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of bacterial infection treatment through his innovative research and patent work. His expertise lies in addressing the challenges posed by emerging tetracycline resistance enzymes.
Latest Patents
Joseph Vogel holds a patent titled "Inhibition and diagnostics of emerging tetracycline resistance enzymes." This patent provides compositions and methods for treating bacterial infections in a subject. The methods involve administering a compound that binds a FAD-dependent flavoenzyme along with a tetracycline, analog, derivative, or pharmaceutically acceptable salt thereof. He has 1 patent to his name.
Career Highlights
Joseph Vogel is affiliated with Washington University, where he conducts research and develops innovative solutions for combating bacterial infections. His work is crucial in the ongoing battle against antibiotic resistance, which poses a significant threat to public health.
Collaborations
Throughout his career, Joseph has collaborated with notable researchers, including Gautam Dantas and Jooyoung Park. These collaborations have furthered the understanding and development of effective treatments for bacterial infections.
Conclusion
Joseph Vogel's contributions to the field of bacterial resistance treatment highlight his dedication to innovation and research. His work is essential in the fight against antibiotic resistance, making a significant impact on public health.